QIAGEN N.V. Operating Expenses 2011-2026 | QGEN

Annual Operating Expenses QIAGEN N.V.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	821 M	695 M	692 M	734 M	769 M	746 M	651 M	704 M	752 M	654 M	650 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
821 M	650 M	715 M

Operating Expenses of other stocks in the Diagnostics research industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	47.4 M	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	58 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	131 M	-	-	$ 1.31 B	USA
Quest Diagnostics Incorporated DGX	1.46 B	$ 203.06	-0.38 %	$ 22.5 B	USA
Celcuity CELC	172 M	$ 88.55	-1.05 %	$ 4.14 B	USA
Akumin AKU	778 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	50.6 M	$ 4.29	-8.72 %	$ 5.71 M	USA
Fulgent Genetics FLGT	222 M	$ 18.68	-0.53 %	$ 575 M	USA
Castle Biosciences CSTL	59.5 M	$ 20.7	-1.48 %	$ 600 M	USA
Aspira Women's Health AWH	13.8 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	77.2 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	21.6 M	-	-13.05 %	$ 7.29 M	USA
ICON Public Limited Company ICLR	408 M	$ 146.18	-2.49 %	$ 11.5 B	Irlanda
Oxford Immunotec Global PLC OXFD	59.4 M	-	-	$ 562 M	Britain
Guardant Health GH	226 M	$ 131.62	0.55 %	$ 16.5 B	USA
CareDx, Inc CDNA	411 M	$ 22.97	-2.92 %	$ 1.22 B	USA
Chembio Diagnostics CEMI	28.5 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	14.1 M	-	-	$ 9.42 M	Israel
Interpace Biosciences IDXG	20 M	$ 1.6	-3.03 %	$ 7.08 M	USA
Illumina ILMN	2.06 B	$ 160.97	-3.15 %	$ 25 B	USA
HTG Molecular Diagnostics HTGM	24.1 M	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	451 M	-	-	$ 399 M	China
National Research Corporation NRC	38.5 M	$ 18.79	-	$ 421 M	USA
Fluidigm Corporation FLDM	134 M	-	1.08 %	$ 308 M	USA
Natera NTRA	258 M	$ 212.07	-3.27 %	$ 29 B	USA
Genetic Technologies Limited GENE	5.91 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	983 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	104 M	-	-11.32 %	$ 2.94 M	USA
Pacific Biosciences of California PACB	600 M	$ 1.31	-2.96 %	$ 393 M	USA
Lantheus Holdings LNTH	123 M	$ 104.52	0.19 %	$ 7.05 B	USA
Charles River Laboratories International CRL	607 M	$ 187.51	-0.29 %	$ 9.29 B	USA
PRA Health Sciences, Inc. PRAH	585 M	-	-	$ 10.7 B	USA
Medpace Holdings MEDP	118 M	$ 467.34	-1.63 %	$ 13.5 B	USA
Exact Sciences Corporation EXAS	2.47 B	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	1.01 B	$ 1 131.49	-0.86 %	$ 23.3 B	Schweiz
NeoGenomics NEO	430 M	$ 11.15	-2.79 %	$ 1.43 B	USA
Myriad Genetics MYGN	964 M	$ 4.33	-6.48 %	$ 401 M	USA
Personalis PSNL	44.5 M	$ 9.59	1.8 %	$ 856 M	USA
Koninklijke Philips N.V. PHG	7.12 B	$ 26.46	1.34 %	$ 25.1 B	Niderland
Twist Bioscience Corporation TWST	116 M	$ 76.17	2.86 %	$ 4.56 B	USA
Senseonics Holdings SENS	61.8 M	$ 7.18	-2.05 %	$ 300 M	USA
Soleno Therapeutics SLNO	181 M	-	-	$ 2.69 B	USA
Biomerica BMRA	5.64 M	$ 2.05	-1.91 %	$ 4.71 M	USA
Laboratory Corporation of America Holdings LH	1.87 B	$ 266.16	0.34 %	$ 22.1 B	USA
Thermo Fisher Scientific TMO	7.15 B	$ 469.34	-1.33 %	$ 177 B	USA
Trinity Biotech plc TRIB	28.3 M	$ 0.65	-3.7 %	$ 233 M	Irlanda
Motus GI Holdings MOTS	19.1 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	1.48 B	$ 9.1	-1.57 %	$ 1.97 B	USA
Invitae Corporation NVTA	343 M	-	-	$ 21.2 M	USA